Stephen Crystal
Overview
Explore the profile of Stephen Crystal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
253
Citations
5137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stone E, Bonsignore S, Crystal S, Samples H
Health Serv Res
. 2025 Mar;
:e14598.
PMID: 40034023
Objective: To examine patient-reported experiences of healthcare services by disability status. Study Setting And Design: We conducted a cross-sectional analysis of Consumer Assessment of Healthcare Providers and Systems (CAHPS) measures...
2.
Doonan S, Wheeler-Martin K, Davis C, Mauro C, Bruzelius E, Crystal S, et al.
Int J Drug Policy
. 2025 Jan;
137:104713.
PMID: 39847857
Background: Identifying the most effective state laws and provisions to reduce opioid overdose deaths remains critical. Methods: Using expert ratings of opioid laws, we developed annual state scores for three...
3.
Bazazi A, Thomas M, Vittinghoff E, Walkup J, Hermida R, Arnold E, et al.
J Acquir Immune Defic Syndr
. 2025 Jan;
PMID: 39847446
Background: People with schizophrenia spectrum disorders are at elevated risk of HIV, and people with both HIV and schizophrenia are at elevated risk of death compared to individuals with either...
4.
Martins S, Bruzelius E, Mauro C, Santaella-Tenorio J, Boustead A, Wheeler-Martin K, et al.
Int J Drug Policy
. 2025 Jan;
136:104687.
PMID: 39793270
Background: Wider availability of cannabis through medical and recreational legalization (MCL alone and RCL+MCL) has been hypothesized to contribute to reductions in opioid use, misuse, and related harms. We examined...
5.
Samples H, Lloyd K, Ryali R, Martins S, Cerda M, Hasin D, et al.
Health Serv Res
. 2025 Jan;
e14429.
PMID: 39748217
Objective: To evaluate the completeness and quality of Medicaid comprehensive managed care (CMC) data in national MAX/TAF research files. Study Setting And Design: This observational study compared CMC with fee-for-service...
6.
Rege S, Parlett L, Neikirk A, Iizuka A, Yang Y, Huang C, et al.
J Clin Rheumatol
. 2024 Dec;
31(1):40-44.
PMID: 39705125
Background/objective: Little is known about the rates of rheumatic disease diagnosis among children during the COVID-19 pandemic. We examined the impact of the pandemic on the diagnosis of juvenile idiopathic...
7.
Wang E, Patorno E, Khosrow-Khavar F, Crystal S, Dave C
Diabetologia
. 2024 Nov;
68(1):94-104.
PMID: 39514094
Aims/hypothesis: The aim of this study was to investigate racial and ethnic disparities in the use of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor antagonists (GLP-1RAs) among older...
8.
Mannes Z, Nowels M, Mauro C, Cook S, Wheeler-Martin K, Gutkind S, et al.
J Gen Intern Med
. 2024 Oct;
PMID: 39354252
Background: U.S. state electronic prescription drug monitoring programs (PDMPs) are associated with reduced opioid dispensing among people with chronic pain and may impact use of other chronic pain treatments. In...
9.
Khan M, Acri M, Ban K, Scheidell J, Stevens E, Manandhar-Sasaki P, et al.
AJPM Focus
. 2024 Sep;
3(5):100258.
PMID: 39290574
Introduction: Depressive symptoms are linked with pain, anxiety, and substance use. Research estimating whether a reduction in depressive symptoms is linked to subsequent reductions in pain and anxiety symptoms and...
10.
Williams A, Mauro C, Chiodo L, Huber B, Cruz A, Crystal S, et al.
Drug Alcohol Depend
. 2024 Aug;
263:112389.
PMID: 39154558
Background: Challenges to engagement and retention on buprenorphine undermine treatment of individuals with opioid use disorder (OUD). Under the OUD Cascade of Care framework, we sought to identify patient characteristics...